Q-omics provides the consensus-scored MIR6885 profile across patient tissues and cancer cell-line models. MIR6885 expression is associated with patient survival in 13 of 34 cancer types, with the highest sampling consensus in KIRC. Additionally, MIR6885 RNA expression shows 4,541 significant pathway-activity associations, with the highest sampling consensus in KIRP. Together, these results highlight KIRC, and KIRP as cancer lineages where MIR6885 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.